Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1915 2
1917 1
1921 1
1924 1
1927 1
1928 1
1931 2
1932 2
1936 1
1937 1
1942 1
1946 2
1947 2
1948 2
1949 1
1950 7
1951 6
1952 2
1953 8
1954 5
1955 6
1956 2
1958 4
1959 4
1960 1
1961 4
1962 9
1963 25
1964 34
1965 33
1966 16
1967 39
1968 75
1969 76
1970 86
1971 102
1972 127
1973 135
1974 114
1975 162
1976 145
1977 151
1978 156
1979 193
1980 154
1981 185
1982 175
1983 231
1984 245
1985 271
1986 289
1987 293
1988 318
1989 396
1990 376
1991 414
1992 425
1993 448
1994 421
1995 503
1996 533
1997 432
1998 506
1999 523
2000 565
2001 565
2002 505
2003 575
2004 530
2005 582
2006 516
2007 506
2008 521
2009 481
2010 500
2011 562
2012 483
2013 479
2014 481
2015 505
2016 500
2017 515
2018 518
2019 472
2020 506
2021 594
2022 482
2023 487
2024 198

Text availability

Article attribute

Article type

Publication date

Search Results

20,184 results

Results by year

Filters applied: . Clear all
Page 1
Fibrosis of Peritoneal Membrane as Target of New Therapies in Peritoneal Dialysis.
Masola V, Bonomini M, Borrelli S, Di Liberato L, Vecchi L, Onisto M, Gambaro G, Palumbo R, Arduini A. Masola V, et al. Int J Mol Sci. 2022 Apr 27;23(9):4831. doi: 10.3390/ijms23094831. Int J Mol Sci. 2022. PMID: 35563220 Free PMC article. Review.
Peritoneal dialysis (PD) is an efficient renal replacement therapy for patients with end-stage renal disease. ...Lastly, we summarize the present and future strategies for developing more biocompatible PD solutions....
Peritoneal dialysis (PD) is an efficient renal replacement therapy for patients with end-stage renal disease. ...Lastly …
The impact of dialysis modality and membrane characteristics on intradialytic hypotension.
Patel S, Raimann JG, Kotanko P. Patel S, et al. Semin Dial. 2017 Nov;30(6):518-531. doi: 10.1111/sdi.12636. Epub 2017 Jul 13. Semin Dial. 2017. PMID: 28707330 Review.
This literature search revealed 669 publications on dialysis modality, 64 on dialysis membrane, and 24 on acetate/bicarbonate dialysate. After omission of duplicate papers and publications outside the scope of this review, we selected 34 papers for inc …
This literature search revealed 669 publications on dialysis modality, 64 on dialysis membrane, and 24 on acetate/bicar …
Assessment and Management of Hypertension among Patients on Peritoneal Dialysis.
Vaios V, Georgianos PI, Liakopoulos V, Agarwal R. Vaios V, et al. Clin J Am Soc Nephrol. 2019 Feb 7;14(2):297-305. doi: 10.2215/CJN.07480618. Epub 2018 Oct 19. Clin J Am Soc Nephrol. 2019. PMID: 30341090 Free PMC article. Review.
Although management of hypertension uses similar therapeutic principles, long-term preservation of residual diuresis and longevity of peritoneal membrane function require particular attention in the prescription of the appropriate dialysis regimen among those on PD. …
Although management of hypertension uses similar therapeutic principles, long-term preservation of residual diuresis and longevity of perito …
Blood-membrane interactions during dialysis.
Huang Z, Gao D, Letteri JJ, Clark WR. Huang Z, et al. Semin Dial. 2009 Nov-Dec;22(6):623-8. doi: 10.1111/j.1525-139X.2009.00658.x. Semin Dial. 2009. PMID: 20017832 Review.
In extracorporeal renal replacement therapies, the dialyzer is not only the site at which solute removal occurs but also the extracorporeal circuit component having the largest surface area exposed to blood. Therefore, it is not surprising that interactions between …
In extracorporeal renal replacement therapies, the dialyzer is not only the site at which solute removal occurs but also the e …
Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress.
Roumeliotis S, Dounousi E, Salmas M, Eleftheriadis T, Liakopoulos V. Roumeliotis S, et al. Biomolecules. 2020 May 14;10(5):768. doi: 10.3390/biom10050768. Biomolecules. 2020. PMID: 32423139 Free PMC article. Review.
One of the main limitations to successful long-term use of peritoneal dialysis (PD) as a renal replacement therapy is the harmful effects of PD solutions to the structure and function of the peritoneal membrane (PM). In PD, the PM serves as a semiperme …
One of the main limitations to successful long-term use of peritoneal dialysis (PD) as a renal replacement therapy is the harm …
Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.
Pletinck A, Vanholder R, Veys N, Van Biesen W. Pletinck A, et al. Nat Rev Nephrol. 2012 Sep;8(9):542-50. doi: 10.1038/nrneph.2012.144. Epub 2012 Jul 10. Nat Rev Nephrol. 2012. PMID: 22777203 Review.
Functional deterioration of the peritoneal membrane in patients on peritoneal dialysis has been described as being the result of a combination of neoangiogenesis and fibrosis. Glucose, glucose degradation products, and the unphysiological pH of the dialysate
Functional deterioration of the peritoneal membrane in patients on peritoneal dialysis has been described as being the result …
Verification of physicochemical structures of dialysis membrane using reversal dialysis technique.
Yamashita AC, Ono T, Tomisawa N. Yamashita AC, et al. Hemodial Int. 2017 Oct;21 Suppl 2:S3-S9. doi: 10.1111/hdi.12595. Hemodial Int. 2017. PMID: 29064175
OBJECTIVE: Solute removal performance of the dialyzer is closely related to physicochemical structures of the membrane. ...This must be based on the fact that the membrane permeability in the reversal dialysis is much larger than that in the normal …
OBJECTIVE: Solute removal performance of the dialyzer is closely related to physicochemical structures of the membrane. ...Thi …
Renal Association Clinical Practice Guideline on Haemodialysis.
Ashby D, Borman N, Burton J, Corbett R, Davenport A, Farrington K, Flowers K, Fotheringham J, Andrea Fox RN, Franklin G, Gardiner C, Martin Gerrish RN, Greenwood S, Hothi D, Khares A, Koufaki P, Levy J, Lindley E, Macdonald J, Mafrici B, Mooney A, Tattersall J, Tyerman K, Villar E, Wilkie M. Ashby D, et al. BMC Nephrol. 2019 Oct 17;20(1):379. doi: 10.1186/s12882-019-1527-3. BMC Nephrol. 2019. PMID: 31623578 Free PMC article.
This section deals with membranes (the type of "filter" used in the dialysis machine) and "HDF" (haemodiafiltration) which is a more complex kind of dialysis which some doctors think is better. ...There is a section on dialysate buffer (bicarbonate) an …
This section deals with membranes (the type of "filter" used in the dialysis machine) and "HDF" (haemodiafiltration) which is …
Biocompatible dialysis fluids for peritoneal dialysis.
Htay H, Johnson DW, Wiggins KJ, Badve SV, Craig JC, Strippoli GF, Cho Y. Htay H, et al. Cochrane Database Syst Rev. 2018 Oct 26;10(10):CD007554. doi: 10.1002/14651858.CD007554.pub3. Cochrane Database Syst Rev. 2018. PMID: 30362116 Free PMC article.
BACKGROUND: Biocompatible peritoneal dialysis (PD) solutions, including neutral pH, low glucose degradation product (GDP) solutions and icodextrin, have previously been shown to favourably influence some patient-level outcomes, albeit based on generally sub-o …
BACKGROUND: Biocompatible peritoneal dialysis (PD) solutions, including neutral pH, low glucose degradation product (GDP) s
20,184 results
You have reached the last available page of results. Please see the User Guide for more information.